4/3
08:00 am
wgs
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
Low
Report
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication
3/22
05:57 pm
wgs
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? [Yahoo! Finance]
Low
Report
Is GeneDx Holdings (WGS) The High Growth Low Debt Stock to Invest in Now? [Yahoo! Finance]
3/20
04:05 pm
wgs
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/18
07:05 am
wgs
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
Medium
Report
Fast Company Recognizes GeneDx as One of the World's Most Innovative Companies
3/14
10:50 am
wgs
Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now? [Yahoo! Finance]
Low
Report
Is GeneDx Holdings Corp. (WGS) the Best Emerging Technology Stock to Buy Now? [Yahoo! Finance]
3/13
08:30 am
wgs
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
Low
Report
GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis
3/13
08:30 am
wgs
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
Low
Report
GeneDx to Showcase Key Research and Innovation at the 2025 American College of Medical Genetics (ACMG) Annual Meeting
3/11
12:19 pm
wgs
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
3/4
08:30 am
wgs
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
Medium
Report
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
3/3
01:09 pm
wgs
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp - WGS
High
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp - WGS
2/25
05:00 pm
wgs
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
2/24
11:00 am
wgs
Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols
Low
Report
Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols
2/24
09:18 am
wgs
4 Healthcare Stocks to Buy as the Sector Stages a Comeback [Yahoo! Finance]
Low
Report
4 Healthcare Stocks to Buy as the Sector Stages a Comeback [Yahoo! Finance]
2/19
09:51 am
wgs
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $70.00 to $80.00. They now have a "neutral" rating on the stock.
Low
Report
GeneDx Holdings Corp. (NASDAQ: WGS) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $70.00 to $80.00. They now have a "neutral" rating on the stock.
2/19
03:29 am
wgs
GeneDx Holdings Corp (WGS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
Low
Report
GeneDx Holdings Corp (WGS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
2/19
12:37 am
wgs
Q4 2024 GeneDx Holdings Corp Earnings Call [Yahoo! Finance]
Low
Report
Q4 2024 GeneDx Holdings Corp Earnings Call [Yahoo! Finance]
2/18
06:27 pm
wgs
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
2/18
09:45 am
wgs
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
High
Report
GeneDx Holdings Corp. (WGS) Q4 Earnings and Revenues Surpass Estimates [Yahoo! Finance]
2/18
06:00 am
wgs
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025
High
Report
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025
2/13
08:30 am
wgs
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
High
Report
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
2/12
04:05 pm
wgs
GeneDx to Participate in 45th Annual TD Cowen Health Care Conference
Medium
Report
GeneDx to Participate in 45th Annual TD Cowen Health Care Conference
2/11
05:20 pm
wgs
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
2/10
08:30 am
wgs
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
High
Report
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
1/28
04:30 pm
wgs
GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025
Medium
Report
GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025
1/21
11:43 am
wgs
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green [Yahoo! Finance]
Neutral
Report
Institutional owners may ignore GeneDx Holdings Corp.'s (NASDAQ:WGS) recent US$427m market cap decline as longer-term profits stay in the green [Yahoo! Finance]